You Are Here: Home > Researchers > Patient Engagement > Study Recruitment

Study Recruitment

Explore

Study Recruitment

Through studies such as these, arthritis will be better understood and new and improved approaches to management will be identified and implemented. We hope to:

  • link you with Canadian researchers who are using the Internet, telephone or mail to conduct national arthritis research;
  • provide you with opportunities to participate in research studies in your geographic region, if available
  • provide an opportunity for people with arthritis from across Canada to be able to participate in arthritis research from the comfort of their homes.

Please note: The research studies listed on this site have received ethics committee approval. The opportunities posted here do not include clinical trials.

How can I submit my study?

Download the Patient Study Checklist [PDF] and submit it to research@arthritis.ca / 1.800. 321.1433. Please note that we will not post opportunities that do not meet the criteria set out in our policy.

Current Studies

  • A Study of barriers, facilitators, expectations and preferences of joint protection programs for patients with hand arthritis

    Principal Investigator: Dr. Joy Christine MacDermid 
    Student Investigator: Leah Catherine Kocherry 
    Co-Investigator: Pavlos Bobos

    The Study:
    You are invited to complete an online survey that will take about 35-40 minutes. As part of the graduate program in the School of Rehabilitation Sciences at McMaster University, researchers are carrying out a study to gain a better understanding of your priorities and goals, specific to joint protection. Your answers to these questions will help them create more effective joint protection programs for you in the future.

    Joint protection is a self-management approach which can help people with hand arthritis (OA and RA) to decrease pain, prevent joint deformities and improve hand function. Joint protection programs are designed to help people learn joint protection strategies and how to use assistive devices. More specifically, joint protection programs involve training on “safer movement patterns, the use of adaptive devices (e.g. built up handles, hands free technologies) and behaviour modifications (e.g. activities to avoid, pacing).

    Eligibility Criteria:

    • The participant is able and willing to provide informed consent 
    • The participant is 18 - 85 years old 
    • The participant is of any gender 
    • The participant has been diagnosed with any form of hand arthritis (e.g. hand osteoarthritis, rheumatoid arthritis in the hand, psoriatic arthritis).
    • The participant can read and write English.

    To participate in this study, please click this link: https://uwo.eu.qualtrics.com/jfe/form/SV_7VypsnnTyZSSHt3 

    Questions about the Study: If you have questions or need more information about the study itself, please contact kocherlc@mcmaster.ca or 905-979-7666 or pbobos@uwo.ca

    This study has been reviewed by the Hamilton Integrated Research Ethics Board (HIREB).

  • Inside Trials - An interview of clinical trials and clinical reporting

    Researchers are inviting individuals with arthritis who have previously taken part in a clinical trial of a prescription drug to participate in an interview study to share their experiences of taking part in a trial.

    Why participate in this study? Patients play a key role in research as participants in clinical trials and learning about trials from the patient perspective is important for improving arthritis research. We are interested to learn more about the experiences and views of people who have taken part in a clinical trial. As part of the study, we would like to find out how trial participants view the importance of publishing the results of trial research.

    Those who can take part in the study have:

    • Participated in a clinical trial of a prescription drug prior to the last 12 months and within the last 5 years,
    • participated in the trial as a patient with arthritis or another health condition (rather than as a “healthy volunteer”), and 
    • were 18 years or older when participating in the trial.

    Participating in this study would involve taking part in an interview of about 60 minutes and possibly a 30-minute follow-up interview. Interviews will be held in Victoria and Vancouver. In order to acknowledge the time taken to participate in this project, each participant will receive an honorarium of $50. 

    Additional information about the study: The study will also involve interviews with clinical trial investigators, university administrators, research ethics board members and individuals who have participated in other types of clinical drug trials to provide additional perspectives on clinical trials and trial reporting. The closing date of the project is August 31, 2021.

    Contact Details: Those interested in participating or finding out more information can contact Co-Investigator Richard Morrow at rlmorrow@mail.ubc.ca or visit www.insidetrialsstudy.ca

    This study received ethics approval (#H18-03458) through the University of British Columbia
    Behavioural Research Ethics Board.

  • @Work: A study of millennials with rheumatic conditions

    What support do you need at work? Help us develop recommendations for employers. If you're 18-35 & live with juvenile arthritis, lupus or another rheumatic condition, we want to hear from you.

    Learn more: https://tinyurl.com/ArthritisEmploymentStudy

  • Coronary artery disease and inflammatory arthritis

    Coronary artery disease (CAD) is more common in women with inflammatory arthritis. Inflammatory arthritis pain can present as chest and shoulder pain and is difficult to distinguish from cardiac pain.

    If you are a woman greater than 55 years of age with rheumatologist diagnosed inflammatory arthritis (rheumatoid psoriatic or ankylosing spondylitis) and established CAD (history of MI, percutaneous intervention [PCI], and/or coronoary artery bypass graft surgery) and interested in participating in a focus group to inform the development of an innovative mobile and web-based health solution for women, please contact Dr. Monica Parry.

    Contact details:

    Dr. Monica Parry, University of Toronto
    (416) 946-3561
    Monica.parry@utoronto.ca

    Sessions will be one hour in length. Refreshment and a $25 gift card will be provided.

    This research project received ethics approval (#34908) through the University of Toronto Research Ethics Committee.

  • Exercise & Rheumatoid Arthritis

    Do you have rheumatoid arthritis? Do you want to be more active?

    Researchers at McGill/MUHC are comparing the effects of two different 12-week exercise programs designed for people with RA.

    • Adults 18 to 65 years of age who are not currently exercising
    • Individually supervised exercise program or home-based exercise program
    • Measurement of body composition, resting metabolic rate, muscle strength and other fitness measures before and after the program
    • Participants stay on all usual RA medicines throughout the study

    For more info:

    Call Alex at 514-398-4184 ext 8910
    Email: RAexercisestudy@gmail.com

    This research project received ethics approval (##2018-3192) through the McGill University Health Centre Research Ethics Board.

  • Expectations and educational needs of Canadian rheumatologists, rheumatology fellows and patients in the field of precision medicine

    Principal investigator:  
    Doctor Laetitia Michou, MD, PhD, Rheumatologist CHU de Québec-Université Laval

    Co-investigators:  
    Doctor Louis Bessette, MD, MSc, FRCPC, Rheumatologist CHU de Québec-Université Laval,  
    Doctor Paul R. Fortin, MD, MPH, FRCPC, Rheumatologist CHU de Québec-Université Laval,  
    Doctor Diane Lacaille, MD, MPH, FRCPC, Rheumatologist Arthritis Research Canada, Vancouver,  
    Doctor Joyce Dogba, MD, PhD, Université Laval,
    Jean Légaré, Ph.D, Arthritis Consumer Advisory Board (PIRA),
    Doctor Sophie Ruel-Gagné, Fellow in rheumatology  

    Project Information:   
    Precision medicine, a personalized medicine based on biomarkers, is a booming field. In recent years, there have been a number of global initiatives such as the Human Genome Project, the 100,000 Genomes Project in the United Kingdom and the US Precision Medicine Initiative whose purpose is to offer personalized care to each individual. Pharmacogenomics, a discipline that studies the role of genes in drug response and drug toxicity, is an important part of precision medicine. Some genetic tests are already widely prescribed by rheumatologists to improve patient care, and new tests should gradually appear and help make better treatment decisions.  

    Some studies have also focused on the knowledge and expectations of patients, but none have been done in rheumatology. They demonstrated that patients generally have a favorable attitude to the integration of precision medicine into clinical practice, but that their knowledge and understanding of genetic principles and tests are limited. It is therefore essential to better inform patients so that they are able to consent in a free and informed manner and to understand the results of the tests so as to integrate them into their shared decision-making. This project will assess the expectations and educational needs in the field of precision medicine among patients with rheumatic diseases, with the intent to develop educational tools that meet their needs. 

    Your Participation:   
    For this project, you will have to complete a 20–question survey divided into four sections: experience, knowledge, expectations and educational needs in the field of precision medicine (the estimated time to complete the questionnaire is 10 minutes). 

    Contact Information: 
    If you have questions about the research project, please contact Sophie Ruel-Gagné (sophie.ruel-gagne.1@ulaval.ca), co-investigator of this project. 

    This study has been approved by the CER du CHU de Québec-Université Laval, #2018-4065

  • Referral to rheumatologists by physiotherapists to enhance access to care: ability and acceptability.

    Principal investigators: Debbie Feldman, PhD, Université de Montréal, Sasha Bernatsky, MD PhD, Université McGill, Linda Woodhouse, PhD, University of Alberta 

    Project description and objectives: Our project, funded by the Canadian Initiative for Outcomes in Rheumatology Care (CIORA) of the Canadian Rheumatology Association focuses on the identification process by physiotherapists of newly affected patients with  inflammatory arthritis and the consequences of rapid referral of these patients to rheumatology care. The purpose of the focus groups is to explore how to facilitate appropriate referrals in rheumatology and optimize the care of a patient with inflammatory arthritis. The focus group will be composed of 4-8 patients and the main goal is to help optimize patient care in inflammatory arthritis. 

    If you are interested in further details about this research, please contact Tatiana Rodriguez, Tatiana.orozco.rodriguez@gmail.com. 

    Read the Invitation
  • Research in early detection of osteoarthritis of the hands in women

    We are looking for women between the ages of 30 and 60 years, whose mothers had osteoarthritis in their hands to take part in the study of: “Early osteoarthritis detection in women with hypermobility of the first carpometacarpal joint” 

    As a participant in this study: 

    • You will be asked to answer anonymous questionnaires regarding your health, hand related activities and any hand symptoms you may have
    • You may be asked to have imaging assessment (hand photographs, X-rays and MRI) of your hands 
    • You may be asked if you would be willing to give a blood sample to evaluate protein markers as they pertain to osteoarthritis of the hands. 

    Any Royal University Hospital parking expenses incurred during participation in this study will be reimbursed.

    Contact Details: 
    Email: Arthritis.Research@usask.ca 
    Tel: (306) 844-1458

    This study has been reviewed by and received approval from the Research Ethics Office, University of Saskatchewan

  • The Disability and Pregnancy Study

    The Disability and Pregnancy Study

    Lead Researchers: 
    Dr. Hilary Brown, University of Toronto Scarborough
    Dr. Yona Lunsky, Centre for Addiction and Mental Health

    Research Team Members:
    Dr. Astrid Guttmann, ICES 
    Dr. Susan Havercamp, Ohio State University 
    Dr. Susan Parish, Northeastern University  
    Dr. Joel Ray, St. Michael’s Hospital
    Dr. Simone Vigod, Women’s College Hospital

    What is this study about?
    Researchers at the University of Toronto are doing a study to learn about the experiences and needs of women, trans, and non-binary with disabilities when they are pregnant and having a baby.

    Am I eligible?
    You may be able to be part of this study if:

    • You live in Ontario
    • You are 18 years old or older
    • You had a baby in the last 5 years
    • You have a physical, sensory, intellectual, and/or developmental disability

    What do I have to do?
    You will be asked to take part in an interview about what services you used around the time you were pregnant and if those services were helpful. The interview will take about 1 hour and can be done at a time and place that is good for you. You can do the study, or not do the study. No one will be told about what you choose. The choice you make will not impact any of the services you use now or later.

    What are the benefits of participating?
    You can help us learn how to improve supports for people with disabilities during pregnancy and birth. You will get a $50 gift card to thank you for your time. If you need any supports to participate, like ASL interpretation, these can be arranged. More information can be found here: https://www.youtube.com/watch?v=Lv8hsYKaYUk&feature=youtu.be

    I am interested! Who do I contact?
    Please contact the Study Coordinator, Lesley, by telephone 647-601-4519 or email wiresearch@utsc.utoronto.ca

    This study has been approved by the Health Sciences Research Ethics Board at the University of Toronto. This research is funded by the National Institutes of Health, and is led by researchers at the University of Toronto, in collaboration with the Centre for Addiction & Mental Health, Women’s College Hospital, Ohio State University, St. Michael’s Hospital, Northeastern University, ICES, and an advisory committee that includes women with disabilities and organizations that serve people with disabilities.